Skip to main content
Log in

Voriconazole best value for invasive aspergillosis in Spain

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Domínguez-Gil A, Martín I, García Vargas M, del Castillo A, Díaz S, Sánchez C.Economic evaluation of voriconazole versus caspofungin for the treatment of invasive aspergillosis in Spain. Clinical Drug Investigation 27: 197-205, No. 3, 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Voriconazole best value for invasive aspergillosis in Spain. Pharmacoecon. Outcomes News 525, 5 (2007). https://doi.org/10.2165/00151234-200705250-00013

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705250-00013

Keywords

Navigation